BABA vs MBLY

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

MBLY exhibits severe fundamental weakness as evidenced by a Piotroski F-Score of 2/9, indicating poor financial health and deteriorating operational efficiency. While the company maintains a pristine balance sheet with negligible debt and high liquidity, this is offset by negative revenue growth (-9.00% YoY) and negative profit margins. The stock is in a clear technical downtrend, having lost over 50% of its value in the last six months. Despite an attractive P/B ratio of 0.51 and bullish analyst targets, the deterministic health markers suggest a high-risk profile until growth stabilizes.